- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT00005136
Gezinshartonderzoek (FHS)
Studie Overzicht
Toestand
Gedetailleerde beschrijving
ACHTERGROND:
Vooruitgang in de moleculaire genetica, genetische epidemiologie, populatiegenetica en identificatie van nieuwe risicofactoren en clusters van risicofactoren voor hart- en vaatziekten maakten 1991 een geschikt moment om te profiteren van de uitgebreide informatie over hart- en vaatziekten, preklinische atherosclerose en risicofactoren in individuen die waren onderzocht in lopende, state-of-the-art epidemiologische studies ondersteund door de NHLBI. Door eerstegraadsverwanten te rekruteren uit willekeurige steekproeven van dergelijke gedefinieerde populaties, verkreeg FHS informatie over familiale aggregatie, genetische en omgevingsbijdragen aan variantie in continue variabelen, en de frequentie en verdeling van verhoogde niveaus van risicofactoren en van geselecteerde belangrijke genen in de algemene populatie .
De FHS is geïnitieerd door het personeel en in mei 1990 goedgekeurd door de Clinical Applications and Prevention Advisory Committee. De Requests for Proposals werden uitgebracht in juli 1991. De contracten werden in juni 1992 gegund.
ONTWERP VERHAAL:
Tijdens fase I en II van mei 1992-mei 1996 werden probands, in de leeftijd van 45-69 jaar, samen met hun verwanten gerekruteerd uit de Framingham Heart Study, de Utah Family Tree Study en de locaties van de ARIC Study in North Carolina en Minnesota. deelname aan de Gezinshartstudie. Er werden twee groepen probands geselecteerd, hetzij willekeurig, hetzij op basis van een hoog familierisico op CHD, zoals berekend op basis van gegevens uit de ouderstudie. Aanvullende gegevens over de gezinsstructuur en ziektegeschiedenis werden verzameld van 3.150 probands en 22.909 van hun familieleden. Klinisch onderzoek en follow-up van deze willekeurige families en families met een hoog CHZ-risico werden uitgevoerd bij in totaal 1.253 families, waaronder 5.975 personen, van wie 102 families, waaronder 265 personen, Afro-Amerikaans waren. De onderzoeken omvatten informatie over antropometrie, bloeddruk, ECG, echografie van de halsslagader, longfunctie en bloedchemie. Vragenlijstgegevens omvatten medische en reproductieve geschiedenis, dieet, lichaamsbeweging, tabaks- en alcoholgebruik, opleiding, inkomen en psychosociale factoren, waaronder vijandigheid, sociale steun en stress. Fase I en II omvatten vier veldcentra, een coördinatiecentrum en een centraal bloedlaboratorium.
In augustus 1996 begon fase III toen samenwerkingsovereenkomsten werden toegekend aan een consortium van zeven door onderzoekers geïnitieerde subsidies om moleculair genetische en genetische epidemiologische studies uit te voeren met behulp van gegevens die tijdens fase I en II waren verzameld. Fase III eindigde in juli 2001. Het doel van fase III was om moleculair genetische en genetische epidemiologische studies uit te voeren met behulp van de uitgebreide gegevens over familie- en medische geschiedenis, risicofactoren, levensstijl, bloedmonsters en opgeslagen DNA die eerder door de FHS waren verzameld. Studies omvatten nieuwe moleculaire genetica van kandidaat-genen en genoombrede zoekopdrachten met anonieme markers voor het detecteren, in kaart brengen en karakteriseren van genen voor coronaire hartziekte en atherosclerose. Er werden genetische epidemiologische analyses uitgevoerd die nieuwe informatie opleverden over de familiale aspecten van atherosclerose en intermediaire fenotypes bij Afro-Amerikanen. Fase III omvatte ook vier veldcentra, een centraal laboratorium, een laboratorium voor moleculaire genetica en een coördinatiecentrum.
De studie werd in 2001 vernieuwd als de Family Heart Study - Subclinical Atherosclerosis Network (FHS-SCAN) om analyses van genoombrede scangegevens te voltooien en veelbelovende markers te genotyperen. De studie verwacht 401 informatieve stambomen (3.027 personen) in te schrijven die eerder zijn onderzocht en gegenotypeerd door de NHLBI Family Heart Study om het calciumvolume van de kransslagader en de aorta te kwantificeren om genen te identificeren die geassocieerd zijn met atherosclerose. Bovendien zullen 315 Afro-Amerikaanse broers en zussen (770 individuen) die eerder zijn onderzocht en vergelijkbaar gegenotypeerd door het Hypertension Epidemiology Network (HyperGEN) in één studiecentrum worden onderzocht om deze studievragen in deze minderheidspopulatie te beantwoorden.
Studietype
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
- Kind
- Volwassen
- Oudere volwassene
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Studie plan
Hoe is de studie opgezet?
Medewerkers en onderzoekers
Sponsor
Onderzoekers
- John Eckfeldt, University of Minnesota
- R. Ellison, Boston University
- Gerardo Heiss, University of North Carolina
- Steven Hunt, University of Utah
- Michael Province, Washington University School of Medicine
- Aaron Folsom, University of Minnesota
- Donna Arnett, University of Minnesota
- Mark Leppert, University of Utah
- D.C. Rao, Washington University School of Medicine
- Roger Williams, University of Utah
Publicaties en nuttige links
Algemene publicaties
- Fretts AM, Follis JL, Nettleton JA, Lemaitre RN, Ngwa JS, Wojczynski MK, Kalafati IP, Varga TV, Frazier-Wood AC, Houston DK, Lahti J, Ericson U, van den Hooven EH, Mikkila V, Kiefte-de Jong JC, Mozaffarian D, Rice K, Renstrom F, North KE, McKeown NM, Feitosa MF, Kanoni S, Smith CE, Garcia ME, Tiainen AM, Sonestedt E, Manichaikul A, van Rooij FJ, Dimitriou M, Raitakari O, Pankow JS, Djousse L, Province MA, Hu FB, Lai CQ, Keller MF, Perala MM, Rotter JI, Hofman A, Graff M, Kahonen M, Mukamal K, Johansson I, Ordovas JM, Liu Y, Mannisto S, Uitterlinden AG, Deloukas P, Seppala I, Psaty BM, Cupples LA, Borecki IB, Franks PW, Arnett DK, Nalls MA, Eriksson JG, Orho-Melander M, Franco OH, Lehtimaki T, Dedoussis GV, Meigs JB, Siscovick DS. Consumption of meat is associated with higher fasting glucose and insulin concentrations regardless of glucose and insulin genetic risk scores: a meta-analysis of 50,345 Caucasians. Am J Clin Nutr. 2015 Nov;102(5):1266-78. doi: 10.3945/ajcn.114.101238. Epub 2015 Sep 9.
- Tanaka T, Ngwa JS, van Rooij FJ, Zillikens MC, Wojczynski MK, Frazier-Wood AC, Houston DK, Kanoni S, Lemaitre RN, Luan J, Mikkila V, Renstrom F, Sonestedt E, Zhao JH, Chu AY, Qi L, Chasman DI, de Oliveira Otto MC, Dhurandhar EJ, Feitosa MF, Johansson I, Khaw KT, Lohman KK, Manichaikul A, McKeown NM, Mozaffarian D, Singleton A, Stirrups K, Viikari J, Ye Z, Bandinelli S, Barroso I, Deloukas P, Forouhi NG, Hofman A, Liu Y, Lyytikainen LP, North KE, Dimitriou M, Hallmans G, Kahonen M, Langenberg C, Ordovas JM, Uitterlinden AG, Hu FB, Kalafati IP, Raitakari O, Franco OH, Johnson A, Emilsson V, Schrack JA, Semba RD, Siscovick DS, Arnett DK, Borecki IB, Franks PW, Kritchevsky SB, Lehtimaki T, Loos RJ, Orho-Melander M, Rotter JI, Wareham NJ, Witteman JC, Ferrucci L, Dedoussis G, Cupples LA, Nettleton JA. Genome-wide meta-analysis of observational studies shows common genetic variants associated with macronutrient intake. Am J Clin Nutr. 2013 Jun;97(6):1395-402. doi: 10.3945/ajcn.112.052183. Epub 2013 May 1.
- Djousse L, Arnett DK, Coon H, Province MA, Moore LL, Ellison RC. Fruit and vegetable consumption and LDL cholesterol: the National Heart, Lung, and Blood Institute Family Heart Study. Am J Clin Nutr. 2004 Feb;79(2):213-7. doi: 10.1093/ajcn/79.2.213.
- Jacques PF, Bostom AG, Williams RR, Ellison RC, Eckfeldt JH, Rosenberg IH, Selhub J, Rozen R. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation. 1996 Jan 1;93(1):7-9. doi: 10.1161/01.cir.93.1.7.
- Pankow JS, Folsom AR, Province MA, Rao DC, Eckfeldt J, Heiss G, Shahar E, Wu KK. Family history of coronary heart disease and hemostatic variables in middle-aged adults. Atherosclerosis Risk in Communities Investigators and Family Heart Study Research Group. Thromb Haemost. 1997 Jan;77(1):87-93.
- Higgins M, Province M, Heiss G, Eckfeldt J, Ellison RC, Folsom AR, Rao DC, Sprafka JM, Williams R. NHLBI Family Heart Study: objectives and design. Am J Epidemiol. 1996 Jun 15;143(12):1219-28. doi: 10.1093/oxfordjournals.aje.a008709.
- Borecki IB, Province MA, Rao DC. Power of segregation analysis for detection of major gene effects on quantitative traits. Genet Epidemiol. 1994;11(5):409-18. doi: 10.1002/gepi.1370110503.
- Borecki IB, Province MA, Rao DC. Inferring a major gene for quantitative traits by using segregation analysis with tests on transmission probabilities: how often do we miss? Am J Hum Genet. 1995 Jan;56(1):319-26.
- Wilk JB, Djousse L, Borecki I, Atwood LD, Hunt SC, Rich SS, Eckfeldt JH, Arnett DK, Rao DC, Myers RH. Segregation analysis of serum uric acid in the NHLBI Family Heart Study. Hum Genet. 2000 Mar;106(3):355-9. doi: 10.1007/s004390000243.
- Kronenberg F, Rich SS, Sholinsky P, Arnett DK, Province ME, Myers RH, Eckfeldt JH, Williams RR, Hunt SC. Insulin and hypertension in the NHLBI Family Heart Study: a sibpair approach to a controversial issue. Am J Hypertens. 2000 Mar;13(3):240-50. doi: 10.1016/s0895-7061(99)00177-6.
- Weidner G, Rice T, Knox SS, Ellison RC, Province MA, Rao DC, Higgins MW. Familial resemblance for hostility: the National Heart, Lung, and Blood Institute Family Heart Study. Psychosom Med. 2000 Mar-Apr;62(2):197-204. doi: 10.1097/00006842-200003000-00008.
- Coon H, Leppert MF, Kronenberg F, Province MA, Myers RH, Arnett DK, Eckfeldt JH, Heiss G, Williams RR, Hunt SC. Evidence for a major gene accounting for mild elevation in LDL cholesterol: the NHLBI Family Heart Study. Ann Hum Genet. 1999 Sep;63(Pt 5):401-12. doi: 10.1046/j.1469-1809.1999.6350401.x.
- Hong Y, Leppert MF, Lin J, Hunt SC, Rich SS, Arnett DK, Myers RH, Eckfeldt J, Williams RR, Province MA. No evidence of linkage between the very-low-density lipoprotein receptor gene and fasting serum insulin or homeostasis model assessment insulin resistance index: the National Heart, Lung, and Blood Institute Family Heart Study. Metabolism. 2000 Mar;49(3):293-7. doi: 10.1016/s0026-0495(00)90022-2.
- Li R, Bensen JT, Hutchinson RG, Province MA, Hertz-Picciotto I, Sprafka JM, Tyroler HA. Family risk score of coronary heart disease (CHD) as a predictor of CHD: the Atherosclerosis Risk in Communities (ARIC) study and the NHLBI family heart study. Genet Epidemiol. 2000 Mar;18(3):236-50. doi: 10.1002/(SICI)1098-2272(200003)18:33.0.CO;2-0.
- Ellison RC, Myers RH, Zhang Y, Djousse L, Knox S, Williams RR, Province MA. Effects of similarities in lifestyle habits on familial aggregation of high density lipoprotein and low density lipoprotein cholesterol: the NHLBI Family Heart Study. Am J Epidemiol. 1999 Nov 1;150(9):910-8. doi: 10.1093/oxfordjournals.aje.a010099.
- Bensen JT, Liese AD, Rushing JT, Province M, Folsom AR, Rich SS, Higgins M. Accuracy of proband reported family history: the NHLBI Family Heart Study (FHS). Genet Epidemiol. 1999;17(2):141-50. doi: 10.1002/(SICI)1098-2272(1999)17:23.0.CO;2-Q.
- Siegmund KD, Todorov AA, Province MA. A frailty approach for modelling diseases with variable age of onset in families: the NHLBI Family Heart Study. Stat Med. 1999 Jun 30;18(12):1517-28. doi: 10.1002/(sici)1097-0258(19990630)18:123.0.co;2-4.
- Ellison RC, Zhang Y, Myers RH, Swanson JL, Higgins M, Eckfeldt J. Lewis blood group phenotype as an independent risk factor for coronary heart disease (the NHLBI Family Heart Study). Am J Cardiol. 1999 Feb 1;83(3):345-8. doi: 10.1016/s0002-9149(98)00866-2.
- Hopkins PN, Hunt SC, Schreiner PJ, Eckfeldt JH, Borecki IB, Ellison CR, Williams RR, Siegmund KD. Lipoprotein(a) interactions with lipid and non-lipid risk factors in patients with early onset coronary artery disease: results from the NHLBI Family Heart Study. Atherosclerosis. 1998 Dec;141(2):333-45. doi: 10.1016/s0021-9150(98)00174-9.
- Knox SS, Siegmund KD, Weidner G, Ellison RC, Adelman A, Paton C. Hostility, social support, and coronary heart disease in the National Heart, Lung, and Blood Institute Family Heart Study. Am J Cardiol. 1998 Nov 15;82(10):1192-6. doi: 10.1016/s0002-9149(98)00599-2.
- Pankow JS, Folsom AR, Province MA, Rao DC, Williams RR, Eckfeldt J, Sellers TA. Segregation analysis of plasminogen activator inhibitor-1 and fibrinogen levels in the NHLBI family heart study. Arterioscler Thromb Vasc Biol. 1998 Oct;18(10):1559-67. doi: 10.1161/01.atv.18.10.1559.
- Djousse L, Ellison RC, Zhang Y, Arnett DK, Sholinsky P, Borecki I. Relation between dietary fiber consumption and fibrinogen and plasminogen activator inhibitor type 1: The National Heart, Lung, and Blood Institute Family Heart Study. Am J Clin Nutr. 1998 Sep;68(3):568-75. doi: 10.1093/ajcn/68.3.568.
- Garg UC, Arnett DK, Evans G, Eckfeldt JH. No association between factor V Leiden mutation and coronary heart disease or carotid intima media thickness: the NHLBI Family Heart Study. Thromb Res. 1998 Mar 15;89(6):289-93. doi: 10.1016/s0049-3848(98)00019-x. No abstract available.
- Folsom AR, Pankow JS, Williams RR, Evans GW, Province MA, Eckfeldt JH. Fibrinogen, plasminogen activator inhibitor-1, and carotid intima-media wall thickness in the NHLBI Family Heart Study. Thromb Haemost. 1998 Feb;79(2):400-4.
- Liao D, Myers R, Hunt S, Shahar E, Paton C, Burke G, Province M, Heiss G. Familial history of stroke and stroke risk. The Family Heart Study. Stroke. 1997 Oct;28(10):1908-12. doi: 10.1161/01.str.28.10.1908.
- Djousse L, Pankow JS, Arnett DK, Zhang Y, Hong Y, Province MA, Ellison RC. Alcohol consumption and plasminogen activator inhibitor type 1: the National Heart, Lung, and Blood Institute Family Heart Study. Am Heart J. 2000 Apr;139(4):704-9. doi: 10.1016/s0002-8703(00)90052-8.
- Hunt KJ, Heiss G, Sholinsky PD, Province MA. Familial history of metabolic disorders and the multiple metabolic syndrome: the NHLBI family heart study. Genet Epidemiol. 2000 Dec;19(4):395-409. doi: 10.1002/1098-2272(200012)19:43.0.CO;2-3.
- Knox SS, Adelman A, Ellison RC, Arnett DK, Siegmund K, Weidner G, Province MA. Hostility, social support, and carotid artery atherosclerosis in the National Heart, Lung, and Blood Institute Family Heart Study. Am J Cardiol. 2000 Nov 15;86(10):1086-9. doi: 10.1016/s0002-9149(00)01164-4.
- Coon H, Myers RH, Borecki IB, Arnett DK, Hunt SC, Province MA, Djousse L, Leppert MF. Replication of linkage of familial combined hyperlipidemia to chromosome 1q with additional heterogeneous effect of apolipoprotein A-I/C-III/A-IV locus. The NHLBI Family Heart Study. Arterioscler Thromb Vasc Biol. 2000 Oct;20(10):2275-80. doi: 10.1161/01.atv.20.10.2275.
- Pankow JS, Arnett DK, Borecki IB, Hunt SC, Eckfeldt JH, Folsom AR, Djousse L. Lack of association between the angiotensin-converting enzyme insertion/deletion polymorphism and plasminogen activator inhibitor-1 antigen levels in the National Heart, Lung, and Blood Institute Family Heart Study. Blood Coagul Fibrinolysis. 2000 Sep;11(6):551-8. doi: 10.1097/00001721-200009000-00007.
- Djousse L, Myers RH, Coon H, Arnett DK, Province MA, Ellison RC. Smoking influences the association between apolipoprotein E and lipids: the National Heart, Lung, and Blood Institute Family Heart Study. Lipids. 2000 Aug;35(8):827-31. doi: 10.1007/s11745-000-0591-1.
- Feitosa MF, Borecki I, Hunt SC, Arnett DK, Rao DC, Province M. Inheritance of the waist-to-hip ratio in the National Heart, Lung, and Blood Institute Family Heart Study. Obes Res. 2000 Jul;8(4):294-301. doi: 10.1038/oby.2000.35.
- Tsai MY, Arnett DK, Eckfeldt JH, Williams RR, Ellison RC. Plasma homocysteine and its association with carotid intimal-medial wall thickness and prevalent coronary heart disease: NHLBI Family Heart Study. Atherosclerosis. 2000 Aug;151(2):519-24. doi: 10.1016/s0021-9150(99)00409-8.
- Salomaa V, Pankow J, Heiss G, Cakir B, Eckfeldt JH, Ellison RC, Myers RH, Hiller KM, Brantley KR, Morris TL, Weston BW. Genetic background of Lewis negative blood group phenotype and its association with atherosclerotic disease in the NHLBI family heart study. J Intern Med. 2000 Jun;247(6):689-98. doi: 10.1046/j.1365-2796.2000.00682.x.
- Wilk JB, Djousse L, Arnett DK, Rich SS, Province MA, Hunt SC, Crapo RO, Higgins M, Myers RH. Evidence for major genes influencing pulmonary function in the NHLBI family heart study. Genet Epidemiol. 2000 Jul;19(1):81-94. doi: 10.1002/1098-2272(200007)19:13.0.CO;2-8.
- Hong Y, Rautaharju PM, Hopkins PN, Arnett DK, Djousse L, Pankow JS, Sholinsky P, Rao DC, Province MA. Familial aggregation of QT-interval variability in a general population: results from the NHLBI Family Heart Study. Clin Genet. 2001 Mar;59(3):171-7. doi: 10.1034/j.1399-0004.2001.590305.x.
- Hunt SC, Kronenberg F, Eckfeldt JH, Hopkins PN, Myers RH, Heiss G. Association of plasma bilirubin with coronary heart disease and segregation of bilirubin as a major gene trait: the NHLBI family heart study. Atherosclerosis. 2001 Feb 15;154(3):747-54. doi: 10.1016/s0021-9150(00)00420-2.
- Pankow JS, Folsom AR, Cushman M, Borecki IB, Hopkins PN, Eckfeldt JH, Tracy RP. Familial and genetic determinants of systemic markers of inflammation: the NHLBI family heart study. Atherosclerosis. 2001 Feb 15;154(3):681-9. doi: 10.1016/s0021-9150(00)00586-4.
- Peacock JM, Arnett DK, Atwood LD, Myers RH, Coon H, Rich SS, Province MA, Heiss G. Genome scan for quantitative trait loci linked to high-density lipoprotein cholesterol: The NHLBI Family Heart Study. Arterioscler Thromb Vasc Biol. 2001 Nov;21(11):1823-8. doi: 10.1161/hq1101.097804.
- Feitosa MF, Borecki IB, Rich SS, Arnett DK, Sholinsky P, Myers RH, Leppert M, Province MA. Quantitative-trait loci influencing body-mass index reside on chromosomes 7 and 13: the National Heart, Lung, and Blood Institute Family Heart Study. Am J Hum Genet. 2002 Jan;70(1):72-82. doi: 10.1086/338144. Epub 2001 Nov 16.
- Folsom AR, Pankow JS, Tracy RP, Arnett DK, Peacock JM, Hong Y, Djousse L, Eckfeldt JH; Investigators of the NHBLI Family Heart Study. Association of C-reactive protein with markers of prevalent atherosclerotic disease. Am J Cardiol. 2001 Jul 15;88(2):112-7. doi: 10.1016/s0002-9149(01)01603-4.
- Kronenberg F, Pereira MA, Schmitz MK, Arnett DK, Evenson KR, Crapo RO, Jensen RL, Burke GL, Sholinsky P, Ellison RC, Hunt SC. Influence of leisure time physical activity and television watching on atherosclerosis risk factors in the NHLBI Family Heart Study. Atherosclerosis. 2000 Dec;153(2):433-43. doi: 10.1016/s0021-9150(00)00426-3.
- Djousse L, Myers RH, Province MA, Hunt SC, Eckfeldt JH, Evans G, Peacock JM, Ellison RC. Influence of apolipoprotein E, smoking, and alcohol intake on carotid atherosclerosis: National Heart, Lung, and Blood Institute Family Heart Study. Stroke. 2002 May;33(5):1357-61. doi: 10.1161/01.str.0000014325.54063.1a.
- Djousse L, Pankow JS, Eckfeldt JH, Folsom AR, Hopkins PN, Province MA, Hong Y, Ellison RC. Relation between dietary linolenic acid and coronary artery disease in the National Heart, Lung, and Blood Institute Family Heart Study. Am J Clin Nutr. 2001 Nov;74(5):612-9. doi: 10.1093/ajcn/74.5.612.
- Hunt SC, Ellison RC, Atwood LD, Pankow JS, Province MA, Leppert MF. Genome scans for blood pressure and hypertension: the National Heart, Lung, and Blood Institute Family Heart Study. Hypertension. 2002 Jul;40(1):1-6. doi: 10.1161/01.hyp.0000022660.28915.b1.
- Kronenberg F, Coon H, Ellison RC, Borecki I, Arnett DK, Province MA, Eckfeldt JH, Hopkins PN, Hunt SC. Segregation analysis of HDL cholesterol in the NHLBI Family Heart Study and in Utah pedigrees. Eur J Hum Genet. 2002 Jun;10(6):367-74. doi: 10.1038/sj.ejhg.5200818.
- Coon H, Eckfeldt JH, Leppert MF, Myers RH, Arnett DK, Heiss G, Province MA, Hunt SC. A genome-wide screen reveals evidence for a locus on chromosome 11 influencing variation in LDL cholesterol in the NHLBI Family Heart Study. Hum Genet. 2002 Sep;111(3):263-9. doi: 10.1007/s00439-002-0773-8. Epub 2002 Jul 31.
- Djousse L, Rothman KJ, Cupples LA, Arnett DK, Ellison RC; NHLBI Family Heart Study. Relation between serum albumin and carotid atherosclerosis: the NHLBI Family Heart Study. Stroke. 2003 Jan;34(1):53-7. doi: 10.1161/01.str.0000048675.97975.84.
- Jacques PF, Bostom AG, Selhub J, Rich S, Ellison RC, Eckfeldt JH, Gravel RA, Rozen R; National Heart, Lung and Blood Institute, National Institutes of Health. Effects of polymorphisms of methionine synthase and methionine synthase reductase on total plasma homocysteine in the NHLBI Family Heart Study. Atherosclerosis. 2003 Jan;166(1):49-55. doi: 10.1016/s0021-9150(02)00204-6.
- Djousse L, Folsom AR, Province MA, Hunt SC, Ellison RC; National Heart, Lung, and Blood Institute Family Heart Study. Dietary linolenic acid and carotid atherosclerosis: the National Heart, Lung, and Blood Institute Family Heart Study. Am J Clin Nutr. 2003 Apr;77(4):819-25. doi: 10.1093/ajcn/77.4.819.
- Wilk JB, DeStefano AL, Arnett DK, Rich SS, Djousse L, Crapo RO, Leppert MF, Province MA, Cupples LA, Gottlieb DJ, Myers RH. A genome-wide scan of pulmonary function measures in the National Heart, Lung, and Blood Institute Family Heart Study. Am J Respir Crit Care Med. 2003 Jun 1;167(11):1528-33. doi: 10.1164/rccm.200207-755OC. Epub 2003 Mar 13.
- Hopkins PN, Heiss G, Ellison RC, Province MA, Pankow JS, Eckfeldt JH, Hunt SC. Coronary artery disease risk in familial combined hyperlipidemia and familial hypertriglyceridemia: a case-control comparison from the National Heart, Lung, and Blood Institute Family Heart Study. Circulation. 2003 Aug 5;108(5):519-23. doi: 10.1161/01.CIR.0000081777.17879.85. Epub 2003 Jul 7.
- Djousse L, Hunt SC, Arnett DK, Province MA, Eckfeldt JH, Ellison RC. Dietary linolenic acid is inversely associated with plasma triacylglycerol: the National Heart, Lung, and Blood Institute Family Heart Study. Am J Clin Nutr. 2003 Dec;78(6):1098-102. doi: 10.1093/ajcn/78.6.1098.
- Knox SS, Wilk JB, Zhang Y, Weidner G, Ellison RC. A genome scan for hostility: the national heart, lung, and blood institute family heart study. Mol Psychiatry. 2004 Feb;9(2):124-6. doi: 10.1038/sj.mp.4001447. No abstract available.
- Tang W, Miller MB, Rich SS, North KE, Pankow JS, Borecki IB, Myers RH, Hopkins PN, Leppert M, Arnett DK; National Heart, Lung, and Blood Institute Family Heart Study. Linkage analysis of a composite factor for the multiple metabolic syndrome: the National Heart, Lung, and Blood Institute Family Heart Study. Diabetes. 2003 Nov;52(11):2840-7. doi: 10.2337/diabetes.52.11.2840.
- Ellison RC, Zhang Y, Qureshi MM, Knox S, Arnett DK, Province MA; Investigators of the NHLBI Family Heart Study. Lifestyle determinants of high-density lipoprotein cholesterol: the National Heart, Lung, and Blood Institute Family Heart Study. Am Heart J. 2004 Mar;147(3):529-35. doi: 10.1016/j.ahj.2003.10.033.
- Coon H, Singh N, Dunn D, Eckfeldt JH, Province MA, Hopkins PN, Weiss R, Hunt SC, Leppert MF; NHLBI Family Heart Study. TXNIP gene not associated with familial combined hyperlipidemia in the NHLBI Family Heart Study. Atherosclerosis. 2004 Jun;174(2):357-62. doi: 10.1016/j.atherosclerosis.2004.02.004.
- Pankow JS, Heiss G, Evans GW, Sholinsky P, Province MA, Coon H, Ellison RC, Miller MB, Qaqish B. Familial aggregation and genome-wide linkage analysis of carotid artery plaque: the NHLBI family heart study. Hum Hered. 2004;57(2):80-9. doi: 10.1159/000077545.
- Jiang Y, Wilk JB, Borecki I, Williamson S, DeStefano AL, Xu G, Liu J, Ellison RC, Province M, Myers RH. Common variants in the 5' region of the leptin gene are associated with body mass index in men from the National Heart, Lung, and Blood Institute Family Heart Study. Am J Hum Genet. 2004 Aug;75(2):220-30. doi: 10.1086/422699. Epub 2004 Jun 11.
- Djousse L, Arnett DK, Eckfeldt JH, Province MA, Singer MR, Ellison RC. Alcohol consumption and metabolic syndrome: does the type of beverage matter? Obes Res. 2004 Sep;12(9):1375-85. doi: 10.1038/oby.2004.174.
- Djousse L, Pankow JS, Arnett DK, Eckfeldt JH, Myers RH, Ellison RC. Apolipoprotein E polymorphism modifies the alcohol-HDL association observed in the National Heart, Lung, and Blood Institute Family Heart Study. Am J Clin Nutr. 2004 Dec;80(6):1639-44. doi: 10.1093/ajcn/80.6.1639.
- Arnett DK, Miller MB, Coon H, Ellison RC, North KE, Province M, Leppert M, Eckfeldt JH. Genome-wide linkage analysis replicates susceptibility locus for fasting plasma triglycerides: NHLBI Family Heart Study. Hum Genet. 2004 Nov;115(6):468-74. doi: 10.1007/s00439-004-1182-y. Epub 2004 Sep 16.
- Knox SS, Weidner G, Adelman A, Stoney CM, Ellison RC. Hostility and physiological risk in the National Heart, Lung, and Blood Institute Family Heart Study. Arch Intern Med. 2004 Dec 13-27;164(22):2442-8. doi: 10.1001/archinte.164.22.2442.
- Djousse L, Arnett DK, Pankow JS, Hopkins PN, Province MA, Ellison RC. Dietary linolenic acid is associated with a lower prevalence of hypertension in the NHLBI Family Heart Study. Hypertension. 2005 Mar;45(3):368-73. doi: 10.1161/01.HYP.0000154679.41568.e6. Epub 2005 Jan 17.
- Lin JP, Myers RH, Almasy L, Coon HH, Arnett DK, Hong Y, Hunt SC. Linkage of the cholesterol 7alpha-hydroxylase gene and low-density lipoprotein cholesterol conditional on apolipoprotein E association: the National Heart, Lung, and Blood Institute Family Heart Study. Chin Med J (Engl). 2005 Mar 5;118(5):362-9.
- Djousse L, Rautaharju PM, Hopkins PN, Whitsel EA, Arnett DK, Eckfeldt JH, Province MA, Ellison RC; Investigators of the NHLBI Family Heart Study. Dietary linolenic acid and adjusted QT and JT intervals in the National Heart, Lung, and Blood Institute Family Heart study. J Am Coll Cardiol. 2005 May 17;45(10):1716-22. doi: 10.1016/j.jacc.2005.01.060.
- Ellison RC, Zhang Y, Wagenknecht LE, Eckfeldt JH, Hopkins PN, Pankow JS, Djousse L, Carr JJ. Relation of the metabolic syndrome to calcified atherosclerotic plaque in the coronary arteries and aorta. Am J Cardiol. 2005 May 15;95(10):1180-6. doi: 10.1016/j.amjcard.2005.01.046.
- Djousse L, Arnett DK, Carr JJ, Eckfeldt JH, Hopkins PN, Province MA, Ellison RC; Investigators of the NHLBI FHS. Dietary linolenic acid is inversely associated with calcified atherosclerotic plaque in the coronary arteries: the National Heart, Lung, and Blood Institute Family Heart Study. Circulation. 2005 Jun 7;111(22):2921-6. doi: 10.1161/CIRCULATIONAHA.104.489534. Epub 2005 May 31.
Studie record data
Bestudeer belangrijke data
Studie start
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Schatting)
Updates van studierecords
Laatste update geplaatst (Schatting)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- 1006 (Institut Pasteur)
- U01HL056564 (Subsidie/contract van de Amerikaanse NIH)
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .
Klinische onderzoeken op Hartziekten
-
University Hospital TuebingenVoltooidHeart Assist-apparaatDuitsland
-
University of ChicagoVoltooidHartfalen | Heart Assist-apparaat | HyponatremischVerenigde Staten
-
Carmel Medical CenterOnbekendPneumoperitoneum | Heart Output StoornisIsraël
-
Region SkaneAanmelden op uitnodigingHartfalen New York Heart Association (NYHA) Klasse II | Hartfalen New York Heart Association (NYHA) Klasse IIIZweden
-
Medical University of BialystokInstitute of Cardiology, Warsaw, Poland; Medical University of Lodz; Poznan University... en andere medewerkersNog niet aan het wervenHartfalen, systolisch | Hartfalen met verminderde ejectiefractie | Hartfalen New York Heart Association Klasse IV | Hartfalen New York Heart Association Klasse IIIPolen
-
Triple-Gene, LLCIntrexon Corporation; Precigen, IncVoltooidHart-en vaatziekten | Hartfalen | Heart-Assist-apparaatVerenigde Staten
-
University of WashingtonAmerican Heart AssociationVoltooidHartfalen, congestief | Mitochondriale verandering | Hartfalen New York Heart Association Klasse IVVerenigde Staten
-
Novartis PharmaceuticalsVoltooidPatiënten die de behandelingsperiode van 12 maanden van de kernstudie met succes hebben afgerond (de Novo Heart-ontvangers) die geïnteresseerd waren om behandeld te worden met EC-MPS
-
University of PennsylvaniaVoltooidPatiënten met primaire of secundaire diagnose Code of Intrntl Classification of Diseases, 9th Revision, (ICD-9-CM) 410 (Behalve wanneer het 5e cijfer 2 was)Verenigde Staten
-
SpringWorks Therapeutics, Inc.VerkrijgbaarNeurofibromatose Type 1-geassocieerde plexiforme neurofibromen | Histiocytisch neoplasma | Andere MAP-K Pathway Driven Diseases